Devil in the Details: The Impact of the First Interchangeable Biosimilar Insulin
Seventeen voicemails, 14 boxes of Endocrine News, and a Costa Coffee tumbler bought in London in 2019 that was in dire need of a good scrubbing. That’s what awaited me when I returned to my office at the Endocrine Society headquarters in Washington D.C. for the first since March 13, 2020. Honestly, it was good...Happy Accidents: Talking with Nobel Laureate Robert J. Lefkowitz, MD
When Robert J. Lefkowitz, MD, received the Nobel Prize for Chemistry in 2012, that was only part of his storied career as a physician scientist. With a new book on the shelves – and online shopping carts – Lefkowitz talks to Endocrine News about misconceptions about scientists, what inspired him to write a book, and...Gut Instincts: The Endocrinologists Behind the 2020 Warren Alpert Foundation Prize
When the world was thrown into disarray earlier this year due to the COVID-19 pandemic, ENDO 2020 in San Francisco was one of the many casualties. All was not lost, however, as the Endocrine Society quickly regrouped and rebounded and hosted the all new, completely virtual ENDO Online 2020 taking place over two weeks in...Endocrine Society Urges Congress to Increase Funding for NIH
From a Distance: Encouraging Physical Distancing to Slow COVID-19
Endocrine News spoke with J. Larry Jameson, MD, PhD, editor-in-chief, Journal of the Endocrine Society, about his March editorial in the New York Times that urged physical distancing in order to save lives. He discusses the editorial’s impact, the importance of videoconferencing, and COVID-19’s lasting impact on healthcare. On March 24, J. Larry Jameson, MD,...
